Search results

Page results

• World-first genotyping test that could transform care for people with sickle cell

  The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.

• Emma Manuel Szelepet, patient governor

  Having originally studied classics, and having first worked in publishing and in the British Library, I became a lawyer and spent ten years in commercial litigation practice in the City.

• Study looking at whether COVID-19 and flu vaccines can be administered at the same time

  Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.

• 1,000 RSV vaccines administered at UCLH

  UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.

• Having proton beam therapy under general anaesthetic: information for children aged 5-8

  Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information

• Having proton beam therapy under general anaesthetic: information for children aged 1- 4

  Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information.

• Plasma Exchange Service at NHNN

  Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.

• UCLH top trust to work at in England

  Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.

• Bolstering world-class research in Women’s Health at UCLH

  UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.

• First participant in Europe joins new myeloma trial at UCLH

  UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.